Last update 18 Aug 2025

Diphenhydramine Hydrochloride/Naproxen Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Naproxen Sodium/Diphenhydramine Hydrochloride, BAY98-7111, Aleve Pm
Target
COXs x H1 receptor
Action
inhibitors, inverse agonists
Mechanism
COX inhibitors(Cyclooxygenases inhibitors), H1 receptor inverse agonists(Histamine H1 receptor inverse agonists)
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication
Sleep Initiation and Maintenance Disorders
Inactive Indication
Pain, PostoperativeToothache
Originator Organization
Bayer AGBayer AG
Active Organization
Bayer HealthCare
Inactive Organization
Bayer AGBayer AG
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (17 Jan 2014),
Sleep Initiation and Maintenance Disorders
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC14H14NaO3
InChIKeyCNQOEXOJUIMDHW-FVGYRXGTSA-N
CAS Registry26159-34-2
View All Structures (2)

Related

11
Clinical Trials associated with Diphenhydramine Hydrochloride/Naproxen Sodium
NCT04307940
/ CompletedPhase 4
A Randomized, Double-Blind, Placebo-Controlled Trial to Compare the Analgesic Efficacy and Safety of Naproxen Sodium Tablets and Hydrocodone/Acetaminophen Tablets in Postsurgical Dental Pain
NCT03570554
/ CompletedPhase 2
A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale
NCT03448536
/ CompletedPhase 4
A Double-Blind, Randomized, Crossover Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea
100 Clinical Results associated with Diphenhydramine Hydrochloride/Naproxen Sodium
Login to view more data
100 Translational Medicine associated with Diphenhydramine Hydrochloride/Naproxen Sodium
Login to view more data
100 Patents (Medical) associated with Diphenhydramine Hydrochloride/Naproxen Sodium
Login to view more data
100 Deals associated with Diphenhydramine Hydrochloride/Naproxen Sodium
Login to view more data

External Link

KEGGWikiATCDrug Bank
-Diphenhydramine Hydrochloride/Naproxen Sodium
N05C
-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Sleep Initiation and Maintenance Disorders
United States
Bayer HealthCare
17 Jan 2014
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pain, PostoperativePhase 3
United States
Bayer AGBayer AG
01 Oct 2010
ToothachePhase 3
United States
Bayer AGBayer AG
01 Oct 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04307940 (CTgov)
Phase 4
Toothache
221
(Naproxen Sodium)
cgrtwqgebn(homycejtfe) = tawjaoihql czqimoiyky (gfcqenxzlv, 3.09)
View more
-
07 Oct 2021
Placebo
(Placebo)
cgrtwqgebn(homycejtfe) = ssdtnwqyxu czqimoiyky (gfcqenxzlv, 4.35)
View more
NCT03404206 (CTgov)
Phase 4
Toothache | Pain, Postoperative
387
(Naproxen Sodium (Aleve, BAY117031))
cywtgqknba = mxvfxmhzel nebhypfiel (rkycjkwqjn, hblrrnalck - wvwvxymasm)
View more
-
18 Jul 2019
(Ibuprofen (Advil))
cywtgqknba = xfjfgvtluc nebhypfiel (rkycjkwqjn, glqwqqxksb - arwqjzaxnb)
View more
NCT01280591 (Morpheus II, CTgov)
Phase 3
Toothache | Pain, Postoperative
712
(Naproxen Sodium 440 mg / DPH 50 mg (BAY98-7111))
yqmlenwozi(vqrhbhoafo) = achuewqlxe pbuiofyfnq (pqsxfwsvzx, thdrujgjno - romzwzuacq)
View more
-
17 Jun 2014
(Naproxen Sodium 220 mg / DPH 50 mg (BAY98-7111))
yqmlenwozi(vqrhbhoafo) = pjgnpzianv pbuiofyfnq (pqsxfwsvzx, bgxjaaraln - xgrxhykbky)
View more
NCT01495858 (Morpheus/DPH, CTgov)
Phase 3
Toothache | Pain, Postoperative
267
(Naproxen Sodium 440 mg / DPH 25 mg (BAY98-7111))
ixuwdgulbz(gtxkcyhwqp) = xmodspqwyr gwgmsporob (lmmedzhczp, nxirwekqoc - inqbsoainw)
View more
-
17 Jun 2014
(Naproxen Sodium 440 mg (BAYH6689))
ixuwdgulbz(gtxkcyhwqp) = ybcltbftxo gwgmsporob (lmmedzhczp, tlouspqkhp - cqxyyqfnxc)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free